TECHWIRE 30
(CIX: WRAL30)  1,123.00  up arrow+1.19  (0.11 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: Apple)  100.96  down arrow-0.83  (-0.82 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: QUINTILES)  57.32  up arrow+0.32  (0.56 %)  Updated: 06:40 PM EDT, Sep 19 2014
(OP: BASF SE)  99.23  down arrow-0.02  (-0.02 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: BioCryst)  10.93  down arrow-0.17  (-1.53 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: BioDelivery)  17.02  down arrow-0.33  (-1.9 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: CEMP)  9.92  down arrow-0.23  (-2.27 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: Cisco Systems)  25.20  down arrow-0.02  (-0.08 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: Cree)  42.16  down arrow-1.06  (-2.45 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: DARA)  1.18  up arrow+0.07  (6.31 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: EMC CORPORATION)  29.53  down arrow-0.19  (-0.64 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: Extreme Networks)  4.80  down arrow-0.13  (-2.64 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: FB)  77.91  up arrow+0.91  (1.18 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: GLAXOSMITHKLINE)  47.38  up arrow+0.09  (0.19 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: GOOG)  596.08  up arrow+6.81  (1.16 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: IBM)  194.00  up arrow+0.25  (0.13 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NY: LH)  106.12  up arrow+0.06  (0.06 %)  Updated: 06:40 PM EDT, Sep 19 2014
(OP: Lenovo Group)  31.10  down arrow-0.07  (-0.22 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: MRK)  60.49  up arrow+0.18  (0.3 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: Microsoft Corp)  47.52  up arrow+0.84  (1.8 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: NTAP)  43.00  down arrow-0.4  (-0.92 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: NOVARTIS AG)  93.90  down arrow-0.9  (-0.95 %)  Updated: 06:40 PM EDT, Sep 19 2014
(OP: Novozymes A/S)  44.80  up arrow+0.06  (0.13 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: PFIZER)  30.40  down arrow-0.18  (-0.59 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: Pozen)  7.89  down arrow-0.05  (-0.63 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NY: RED HAT)  57.93  down arrow-2.73  (-4.5 %)  Updated: 06:40 PM EDT, Sep 19 2014
(NQ: BBRY)  10.89  up arrow+0.14  (1.3 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: Salix)  164.23  up arrow+4.46  (2.79 %)  Updated: 08:10 PM EDT, Sep 19 2014
(NQ: SQI)  15.96  down arrow-0.39  (-2.39 %)  Updated: 08:10 PM EDT, Sep 19 2014

Posts tagged “N.C. Biotech Center”

Updated 5:53 a.m. Monday

Get noticed by sharing your news with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

September 12

FDA grants 'orphan' drug status to Viamet fungus fighter

Viamet Durham's Viamet Pharmaceuticals has been granted an orphan drug designation by the U.S. Food & Drug Administration for one of its lead drug candidates, an oral antifungal agent code-named VT-1129.

September 11

Agriculture, biotech leaders to gather at NCSU for food 'summit'

AgBiotech Summit Food and agricultural experts from around the nation will join North Carolina peers at the McKimmon Conference Center in Raleigh Nov. 18 and 19 for a wide-ranging discussion of technologies and policies affecting food production.

September 10

Liquidia's spin-out cycle 2: Another new venture is born

Liquidia, itself spun out of the University of North Carolina at Chapel Hill in 2004 by superstar scientists Joe DeSimone and Ed Samulski, has "re-spun" its second new pharmaceutical company, this one to specifically target yet-undisclosed "oral health conditions."

The PRINT platform The PRINT platform

September 9

As Bayer CropScience breaks ground for $30M greenhouse, there's more growth to come

Jim Blome heads one of the world's largest seed companies, but he isn't ready to spill the beans on Bayer CropScience's future plans for expansion on its Research Triangle Park campus.

Rendering of Bayer CropScience's new RTP greenhouse Rendering of Bayer CropScience's new RTP greenhouse

September 8

We want your news: Send company updates to WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

September 5

How to win grants: The 4 commandments for proposals

Research Grant It's no secret that research careers can thrive or die on grant funding. That's why it's always surprising to find bright people with advanced levels of education who just don't know how to make "the ask." Here is advice on how to win at writing grants.

Updated September 2

Premium Lock Dignify Therapeutics wins SBIR grant, aims for $3M in funding

Dignify Therapeutics The drug development company focused on restoring bladder and bowel control to people with spinal injuries has been awarded $159,000 Small Business Innovation Research (SBIR) grant as global market potential for their flagship product continues to grow.

September 2

Your company making news? Share it with WRAL TechWire

Contribute to WRALTechWire WRAL TechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

August 22

Premium Lock Exclusive: New Biotech Center CEO will 'push the envelope with new ideas and programs'

In the second part of an exclusive in-depth Q&A with Doug Edgeton, the new CEO of the North Carolina Biotechnology Center, the veteran life science executive talks about his goals, his background, and the Center's commitment to development of the sector across the state.

Douge Edgeton  Douge Edgeton

August 22

Premium Lock Exclusive: New Biotech Center CEO lays out future vision

Life science veteran executive Doug Edgeton, who once ran the Piedmont Research Park in Winston-Salem, spells out his vision for where he hopes to take the North Carolina Biotechnology Center as its new CEO in an exclusive Q&A with WRAL Tech Wire. He says N.C. has a fight on its hands to grow one of the nation's largest biotech industry clusters. But Edgeton believes he's ready for the job. Restoring state budget cuts is a "top priority" as well as recruiting and helping build new businesses. "We have to be creative in finding ways to bring technologies to the marketplace that will improve lives, create well-paying jobs and create wealth for the people of our state," Edgeton explains.

Doug Edgeton Doug Edgeton

August 21

Premium Lock $15M Marcus Foundation grant boosts cord blood research at Duke

The Duke award enables cell therapy expert Joanne Kurtzberg, M.D., and leading autism authority Geraldine Dawson, Ph.D., professor of psychiatry and behavioral sciences, to pioneer new treatment approaches and cell-based therapies that could potentially benefit many autism patients.

Home Depot co-founder, philanthropist Bernie Marcus. Home Depot co-founder, philanthropist Bernie Marcus.

August 19

Premium Lock $4.1M federal grant could put BioCryst in Ebola fight - next time

It's tempting to think BioCryst might have the club that could beat down the frightening disease that's producing daily headlines out of West Africa. So far it's believed to have infected more than 2,100 people in 2014 and killed 1,145 in Guinea, Liberia, Nigeria and Sierra Leone. But this Ebola outbreak will most likely be history by the time BCX4430 becomes a useful clinical weapon.

Ebola virus    Ebola virus

Updated August 13

Premium Lock N.C. Biotechnology Center promotes exec to CEO post

The North Carolina Biotechnology Center has a new chief executive officer: Doug Edgeton, who already is a senior executive at the Center. He replaces Norris Tolson, who retired June 30.

Doug Edgeton Doug Edgeton

August 11

Premium Lock Report: NC 3rd largest state in biotech; RTP 4th top cluster

Biotech & Life Science Technically North Carolina ranks both third and fourth among the nation's life science hotspots. That's according to a new life science industry report from Jones Lang LaSalle.

August 11

Premium Lock We want your news: Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

August 6

Premium Lock Glenmark Pharma debuts in US with North Carolina plant

An India-based global pharmaceutical company has chosen North Carolina for its first North American manufacturing facility.

New in NC New in NC

July 30

Premium Lock Biotech Center awards $6.3m in loans, grants across state over past year

Dollar sign  The North Carolina Biotechnology Center awarded more than $1.5 million in the fourth quarter of its 2013-2014 fiscal year, while the Center's loan recipients brought in more than $77 million in outside funding during the period. For its fiscal year, the Biotech Center awarded more than $6.3 million in loans and grants.

July 25

Premium Lock Investment firm buys Charlotte-based AGDATA

Office deal Charlotte-based agricultural data company AGDATA has been purchased for an undisclosed sum by a large national investment firm, San Francisco-based Vista Equity Partners.

July 23

Premium Lock Exclusive: Biotech Center doubles size of startup loans due to lack of private investment funding

Despite cuts in its own state funding, the North Carolina Biotechnology Center is doubling the size of loans it makes to early-stage life science companies. Why? Lack of private-sector capital, says Peter Ginsberg, the Center's vice president for business and technology development. WRAL TechWire Insiders can read the details in this exclusive interview.

N.C. Biotech Center   N.C. Biotech Center

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll